Tag | Content |
---|
EnhancerAtlas ID | HS101-35420 |
Organism | Homo sapiens |
Tissue/cell | HT29 |
Coordinate | chr5:118732760-118735150 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
JUN(var.2) | MA0489.1 | chr5:118733377-118733391 | AGAAAATGAGTCAG | + | 6.11 | NKX2-3 | MA0672.1 | chr5:118734286-118734296 | ACCACTTGAA | + | 6.02 | Nr2f6(var.2) | MA0728.1 | chr5:118734159-118734174 | GAGGTCCAGAGTTCA | + | 6.48 | Pou2f3 | MA0627.1 | chr5:118735030-118735046 | TGAAATTTGCATAAGA | - | 6.36 |
|
| Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
SE_09224 | chr5:118728495-118734533 | CD14 | SE_10192 | chr5:118734389-118736126 | CD19_Primary | SE_18242 | chr5:118728140-118736922 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19112 | chr5:118730523-118734910 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_32471 | chr5:118728730-118735385 | GM12878 | SE_61341 | chr5:118718830-118786386 | HBL1 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH05I119397 | chr5 | 118732697 | 118735694 |
|
Enhancer Sequence | TTATATAATA GTATGCCATT CACAATTATC TGGAAAGTTC TTTTTCTCCC ACCATGTGAA 60 TACACACACA CACACACACA CACACACAAT TTTTAAGCCC CCAAAGGCTT AAAATAGTAC 120 TTTTTGTGGT CTGTACCGGT CAGTTGGATT TTTACTAAGA ATTTTAATTT ATCCTTGAGA 180 TACTTGATGA GTGTATATAA GCAGTTGCAA TTTAGCATAC AAAACCTGAC AAATGGTAAA 240 TAAAAGAATA TGTTTATCCA AATGATGAAA TATTTGTAGT AAAAAGTGCT ATTCAATTGC 300 CAGGAAATTA AAATACTCCA GTAAAATGAA TTAAATTAGC ATGTTAATAA GAGTGATAAT 360 ATTTAAAAGT TTTAGTCAAT CTTGCATTTC CATACTTGCA TTATCTAAAC TAGTTGAACT 420 TTTCAGTGTT TTACTTGATA TATTGCATTC TTGAGCATTA GGCTTCTAGG TGATTTGTTA 480 AACTCATAGC AGGTTTTAGT ACACAGTGCT GTTTATGACA GAAAAAATTT TATCCTACCT 540 CTGAAATAAT TGTACTTTCT GTGATTCAGA TAAAAACTTT ATAGAAACTC CCTAATGAAA 600 ATATTGAAGC ATTAACCAGA AAATGAGTCA GCTTTTTGTT TCCAAAATGA TGCAACAGGA 660 AAACCTTTAA CTACTTATAA TCCCGTATAG TCACCATCAC CACGAAGTAT TGAAAATCTG 720 TTTTCTCTTT TACTAAGTGT CTGCACGGTC ACTTATGTAT ACCCAAAGCC AGAAAGATAT 780 TTTTATCTCA GGGAAATTCC AGAAATGGAA ACATTTTTGT GTAATATTGA TTCATTTCTG 840 TCTCACCAAA GATGTGTTTT CCACGTAGCA AAGAACATCA GCCCCACGTT ATAGGGAACA 900 AGCGAGTCCC AAATCGTACC ATCTGCTGAG CACTGAGAAA GGATATGGAC AAGTCAGTCA 960 GCATTCACAA TTAAGAGAAA AACATCTGTG CTTTGGAAAA TGTTCTTCAA GGATAGAGAA 1020 TTGTGCCCTA TGTCCACCAA ATTTGCATGA GATCTTTATA AGATTAGACA GCCAGTGGAT 1080 AAGGCCCCTT ATCTTTCTTC ATGGATGGCT GAGGAAATTC TCCGCCTTCC CTGACATCAG 1140 CTGCATAACT GTATTTCTGC CTCGTGGAAA TAAAGTAGAT GATCAGGCAC TTGCGGTTTG 1200 TTCTTAATAC AAGAAAGACA ATTTGATTTT TAAAAGTTTT GATTTGTAGA ATAATGTAAG 1260 ACAATATGTT TCTTTCTACT TTGGTTTTTC CATTCAAAAG CTTACAGATG AATTCATTCG 1320 TTTAAAACTG CCAGGCTGAG TGCGGTGGCT CATGCCTGTA ATCCCAACAC TTCGGGAGAC 1380 TGAGGTGGGC GGATCACCTG AGGTCCAGAG TTCAAGACCA GCCTGACCAA CATGGTGAAA 1440 CCCCATCTCT ACTAAAAATA CAAAATTAGC CGGGTGCAGT GCCACATGCC TGTAATCCCA 1500 GCTACTTGGG AGGCTGAGGC AGGAGAACCA CTTGAACCCA GGAGGCAGAG GTTGCAGTGA 1560 GCCAAGATTA CACCACTGCA CTCCAGCCTG GGCAACAAGA GTGAGACTTT GTCTCAAAAA 1620 AAAAAAAAGA AACTCTGTCT CGAAGTAAAT AAATAAATTT TTAAAAACCA ACCTGATGTG 1680 AAGTTGAAAC ACAAGACGCG GAAATAAAAA CTCAGAGTAT AAATATCTAT ATTGTTACCA 1740 TTATCTGGGA TAATTGATGA TTTATAAGAA GCTGAGGTTT CGTCTTCCTA GAAATGGACT 1800 TTTATTAGGC CAGCAAGAAT GACCACTTAG CCATTTAAAT GATTTGTCAG CATCTTTTGC 1860 TGCTCTCTTC TAAGACCATT GGTTTTCACT AAAGGATAAA TACCTGCTAA GCAAATTATA 1920 AAATACTATA AGACATTTAA TCTCCTGGAA GAGGACTTGC TGATAATTGG ATCAAAGTTC 1980 CAGCATTATT GCTCTTTTCG AATCATATGG ACTTAGTGTT CTCATGACCG AGGAGTCACA 2040 TTTTTAGCTT GCTAAAATAT TCACTGGAGA ACATGGTGAA ATCCACGAGT GGAAACGTTC 2100 CATGGTATTT TCAAACGCCA CGTGTCAGGA ATTTGGCATG CCTTCCTCTG GGAGAGGCAC 2160 TGGAGTGTGG CCAGATGGAA CCCAGCAGGG TACAGAGGGC ATTTGTGGGA GCAGTTAGGA 2220 AACCAGGACG TCCAGCTTCT GCCTGCCAGG GAGCTCGCTC ATGTTGTCTC TGAAATTTGC 2280 ATAAGAGCAA TTACCTCATA TTCTAATTTT AAAGATACAA TTTTTAAAGA CATGGAAGGC 2340 TCTGAGACCT CCTGAAGGCT ATTCCTATGT GAGGTATTGT TTACGGGTGG 2390
|